Serotonin News and Research

Latest Serotonin News and Research

Cymbalta approved in Europe for generalised anxiety disorder

Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).

24 Aug 2008

Variations in the serotonin transporter gene may determine who responds best to antidepressant

A new Mayo Clinic study shows that variations in the serotonin transporter gene could explain why some people with depression respond better than others to treatment with citalopram (Celexa), an antidepressant medication.

14 Jul 2008

Nicotine clues for dementia treatment

A team of London scientists have found clues for the potentially therapeutic benefits of nicotine on learning, memory and attention while minimising the risk of addiction. The research announced in Geneva Monday will assist the search for new drugs for dementia.

14 Jul 2008

Genetic change in dopamine transporter supports a role for dopamine signaling in ADHD

A genetic change in the dopamine transporter - one of the brain's dopamine-handling proteins - makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in The Journal of Neuroscience.

9 Jul 2008

A suspect found for SIDS

New evidence is suggesting that a chemical imbalance in the brain may be the cause of some cot deaths.

8 Jul 2008

Researchers solve structure of proteins known as sodium glucose co-transporters

Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.

4 Jul 2008

Research sheds light on the molecular basis of SIDS

Sudden Infant Death Syndrome (SIDS) is a condition that unexpectedly and unexplainably takes the lives of seemingly healthy babies aged between a month and a year.

3 Jul 2008

Effects of magic mushrooms long-lasting

Researchers in the United States say the "spiritual" effects of sacred mushrooms can last for more than a year.

2 Jul 2008

Spiritual effects of 'sacred mushrooms' appear to last more than a year

In a follow-up to research showing that psilocybin, a substance contained in "sacred mushrooms," produces substantial spiritual effects, a Johns Hopkins team reports that those beneficial effects appear to last more than a year.

1 Jul 2008

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

16 Jun 2008

Decisions best made on a full stomach

British researchers say decisions are best made on a full stomach. The scientists say a full stomach minimises hasty decisions and prevents impulsive actions.

8 Jun 2008

You may not be what you eat after all!

A new study shows that increased eating does not necessarily lead to increased fat. The finding in the much-studied roundworm opens the possibility of identifying new targets for drugs to control weight, the researchers say.

3 Jun 2008

Thinness versus obesity not directly linked to eating habits

Whether you are fat or thin isn't directly determined by your eating habits, suggest researchers who report new findings made in worms in the June issue of Cell Metabolism, a publication of Cell Press.

3 Jun 2008

Spectral Modeling technology substantiated through creation of antipsychotic bank of drug candidates

LIUS Molecular Design is pleased to announce that it has successfully created two antipsychotic drug candidates with third party confirmation of predicted biological activities via in vitro testing.

19 May 2008

Regenerative medicine offers hope in spinal cord injury

Spinal cord injury (SCI) can be a catastrophic event for the individual. Traditionally, such injuries were viewed as permanent, irreversible neurological dysfunction, but over time research has shown some neuroplastic capability of the injured adult mammalian spinal cord. However, spontaneous functional recovery post-SCI is very modest.

14 May 2008

Researchers find link between altered dopamine activity and social anxiety disorder

Using single-photon emission computed tomography (SPECT), researchers in The Netherlands were able to detect biochemical differences in the brains of individuals with generalized social anxiety disorder (also known as social phobia), providing evidence of a long-suspected biological cause for the dysfunction.

12 May 2008